Skip to content

BeOne Medicines Ltd.

ONC· NasdaqCore metricsCIK 1651308

Pharmaceutical preparations553 peers

Last sale
Nov 12, 2026 · -0.96%
Market cap
$617.76B
1.48B shares
Filings
1,057
$1.89B
Q3 2026+40.2% FY25 yoy
$384.71M
Q3 2026N/M FY25 yoy
$418.68M
Q3 2026N/M FY25 yoy
$1.07B
Q3 2026derivedN/M FY25 yoy
$0.25
Q3 2026N/M FY25 yoy
$5.78B
Q3 2026+73.1% FY25 yoy
$617.76B
674.7×
93.5×
106.1×
0.23%
—

Twelve months to Sep 30, 2026 · derived

Price

$416.02+21.10%+$72.47past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$5.34BFY 2025
$5.34B0FY 2014FY 2019FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$5,343,033,000reported
FY 20242024-12-31$3,810,241,000reported
FY 20232023-12-31$2,458,779,000reported
FY 20222022-12-31$1,415,921,000reported
FY 20212021-12-31$1,176,283,000reported
FY 20202020-12-31$308,874,000reported
FY 20192019-12-31$428,212,000reported
FY 20182018-12-31$198,220,000reported
FY 20172017-12-31$238,387,000reported
FY 20162016-12-31$1,070,000reported
FY 20152015-12-31$8,816,000reported
FY 20142014-12-31$13,035,000reported

Segments

Revenue by Geography, FY2018 to FY2025FY2018United States · FY2018 · $42.79MPRC · FY2018 · $132.39MOther · FY2018 · $23.04MFY2019United States · FY2019 · $134.69MPRC · FY2019 · $221.56MOther · FY2019 · $71.97MFY2020United States · FY2020 · $18.23MPRC · FY2020 · $290.65MFY2021United States · FY2021 · $495.27MPRC · FY2021 · $517.10MEurope- total revenue · FY2021 · $163.05MOther · FY2021 · $863.00KFY2022United States · FY2022 · $502.63MPRC · FY2022 · $840.03MEurope- total revenue · FY2022 · $63.26MOther · FY2022 · $10.01MFY2023United States · FY2023 · $1.13BPRC · FY2023 · $1.10BEurope- total revenue · FY2023 · $202.01MOther · FY2023 · $26.60MOther · FY2023 · $26.60MFY2024United States · FY2024 · $1.96BPRC · FY2024 · $1.41BEurope- total revenue · FY2024 · $362.63MOther · FY2024 · $78.81MOther · FY2024 · $78.81MFY2025United States · FY2025 · $2.88BPRC · FY2025 · $1.68BEurope- total revenue · FY2025 · $611.37MOther · FY2025 · $171.81M
LineFY2025ShareChange
United States$2.88B54%+47.1%
PRC$1.68B31%+19.0%
Europe- total revenue$611.37M11%+68.6%
Other$171.81M3.2%+118.0%
Other———
Total$5.34B

From the 10-K filed Feb 26, 2026ONC

Pharmaceutical preparations

BeOne Medicines Ltd. is the 17th largest of the 554 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

BeOne Medicines Ltd. · CIK 1651308 · Engraved from SEC EDGAR